05/03/2024
6:19 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:21 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:23 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:15 PM | Brady James Aloysius (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:16 PM | Cunningham Kenneth (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:17 PM | SHAH MAHENDRA (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:17 PM | ACKERMANN CHRISTINA (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/30/2024
3:17 PM | EBSWORTH DAVID R (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:17 PM | Ullman Anders (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:17 PM | Edwards Martin (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:18 PM | Sinha Vikas (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:15 PM | Fisher Andrew (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:47 AM | Verona Pharma (Filer)
| Form ARS | |
03/20/2024
7:46 AM | Verona Pharma (Filer)
| Form DEF 14A | |
03/12/2024
6:45 PM | Gupta Rishi (Reporting)
Verona Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
3:18 PM | Verona Pharma (Filer)
| Form PRE 14A | |
03/07/2024
8:40 PM | Fisher Andrew (Reporting)
Verona Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/04/2024
7:15 PM | ORBIMED ADVISORS LLC (Reporting)
Verona Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
8:00 AM | Verona Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/29/2024
5:08 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2024
5:09 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
5:10 PM | Poll Claire (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
5:11 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
5:11 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
5:02 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
5:05 AM | Austwick Michael (Reporting)
Verona Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/02/2024
5:07 AM | Austwick Michael (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
5:02 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
3:15 PM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2023
4:09 PM | Edwards Martin (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
3:15 PM | EBSWORTH DAVID R (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
7:08 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
7:09 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
7:09 PM | Poll Claire (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
7:11 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
3:25 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023
3:16 PM | Verona Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023
5:24 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2023
3:06 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2023
3:06 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2023
5:02 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
The asset beating inflation by 4x (Ad) "Trump Loophole" Beats Inflation?
Inflation has been out of control for years.
Forcing you to work longer and harder for more money that is worth less.
By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties. That's why we have released our Free Precious Metals Investment Guide that explains all the details |
09/05/2023
3:05 PM | ACKERMANN CHRISTINA (Reporting)
Verona Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/05/2023
3:05 PM | ACKERMANN CHRISTINA (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2023
8:15 PM | Poll Claire (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2023
8:17 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2023
8:17 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2023
8:19 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
7:31 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
7:27 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
7:29 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
7:30 PM | Poll Claire (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
3:12 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/03/2023
7:34 AM | Verona Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/03/2023
5:11 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2023
5:06 PM | Gupta Rishi (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2023
5:07 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2023
5:18 PM | ORBIMED ADVISORS LLC (Reporting)
Verona Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2023
7:47 AM | Verona Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2023
5:13 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
